Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co., Inc. announced the acquisition of 392,000 of its own shares, totaling approximately 1.67 billion yen, through open market purchases on the Tokyo Stock Exchange during September 2025. This move is part of a broader strategy approved by the board to acquire up to 3 million shares by the end of 2025, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:4530) stock is a Hold with a Yen4447.00 price target. To see the full list of analyst forecasts on Hisamitsu Pharmaceutical Co stock, see the JP:4530 Stock Forecast page.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a company based in Tosu City, Saga Prefecture, Japan. It operates in the pharmaceutical industry, focusing on the development and sale of healthcare products, including transdermal patches and other medical treatments.
Average Trading Volume: 193,480
Technical Sentiment Signal: Sell
Current Market Cap: Yen297.6B
Find detailed analytics on 4530 stock on TipRanks’ Stock Analysis page.